Artwork

Content provided by Eddy Joe Gutierrez, MD, Eddy Joe Gutierrez, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Eddy Joe Gutierrez, MD, Eddy Joe Gutierrez, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

High Flow Nasal Oxygen or NIV in the Immunocompromised?

8:16
 
Share
 

Manage episode 325985576 series 2774944
Content provided by Eddy Joe Gutierrez, MD, Eddy Joe Gutierrez, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Eddy Joe Gutierrez, MD, Eddy Joe Gutierrez, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In patients who are immunocompromised, we must determine whether using high flow oxygen (HFNC/NHF/HFO) or NIV would better serve our patients

Show Notes: https://eddyjoemd.com/high-flow-immunocompromised/

Although great care has been taken to ensure that the information in this podcast are accurate, eddyjoe, LLC shall not be held responsible or in any way liable for the continued accuracy of the information, or for any errors, omissions or inaccuracies, or for any consequences arising therefrom.

Citation:
Bourenne J, Girault C, Vinsonneau C, Dellamonica J, Labro G, Jochmans S, Herbland A, Quenot JP, Devaquet J, Benzekri D, Vivier E, Nseir S, Colin G, Thevenin D, Grasselli G, Bougon D, Assefi M, Guérin C, Lherm T, Kouatchet A, Ragot S, Thille AW; FLORALI-IM study group and the REVA Research Network. High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial. Lancet Respir Med. 2022 Mar 21:S2213-2600(22)00096-0. doi: 10.1016/S2213-2600(22)00096-0. Epub ahead of print. PMID: 35325620.

--- Support this podcast: https://podcasters.spotify.com/pod/show/eddyjoemd/support
  continue reading

137 episodes

Artwork
iconShare
 
Manage episode 325985576 series 2774944
Content provided by Eddy Joe Gutierrez, MD, Eddy Joe Gutierrez, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Eddy Joe Gutierrez, MD, Eddy Joe Gutierrez, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In patients who are immunocompromised, we must determine whether using high flow oxygen (HFNC/NHF/HFO) or NIV would better serve our patients

Show Notes: https://eddyjoemd.com/high-flow-immunocompromised/

Although great care has been taken to ensure that the information in this podcast are accurate, eddyjoe, LLC shall not be held responsible or in any way liable for the continued accuracy of the information, or for any errors, omissions or inaccuracies, or for any consequences arising therefrom.

Citation:
Bourenne J, Girault C, Vinsonneau C, Dellamonica J, Labro G, Jochmans S, Herbland A, Quenot JP, Devaquet J, Benzekri D, Vivier E, Nseir S, Colin G, Thevenin D, Grasselli G, Bougon D, Assefi M, Guérin C, Lherm T, Kouatchet A, Ragot S, Thille AW; FLORALI-IM study group and the REVA Research Network. High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial. Lancet Respir Med. 2022 Mar 21:S2213-2600(22)00096-0. doi: 10.1016/S2213-2600(22)00096-0. Epub ahead of print. PMID: 35325620.

--- Support this podcast: https://podcasters.spotify.com/pod/show/eddyjoemd/support
  continue reading

137 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide